Acadia Pharmaceuticals Inc. (ACAD)
Market Closed
17 Jul, 20:00
$
25. 60
-0.03
-0.1171%
$
4.49B Market Cap
- P/E Ratio
- Div Yield
1.21M Volume
-0.34 Eps
$ 25.63
Previous Close 
Want to track ACAD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.06 | - |
| | | 0.12 | - |
| | | - | - |
| | | 0.14 | 0.16 |
| | | 0.05 | 0.11 |
| | | 0.22 | 0.86 |
| | | - | - |
| | | 0.19 | - |
| | | 0.05 | - |
| | | 0.05 | 0.1 |
| | | 0.3 | 0.28 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ACAD Earnings Reports FAQ
What is the earnings per share (EPS) for ACAD?
The current EPS is -0.34.
What is the company's earnings growth rate?
Over the past 13 years, the earnings growth rate has been approximately -42.86%, reflecting the ACAD's performance and NASDAQ (NGS) market conditions.
When is the next earnings release date?
Acadia Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Acadia Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ACAD at this time, as Acadia Pharmaceuticals Inc has no recent EPS data to calculate it.
